Business
Aurora and MedReleaf Australia Launch new Medical Cannabis Brand - CraftPlant
Aurora and MedReleaf Australia Launch new Medical Cannabis Brand - CraftPlant Canada Ne...
About this update from Aurora Cannabis Inc.
[{"type":"text","content":"\n \n \n \n Aurora and MedReleaf Australia Launch new Medical Cannabis Brand - CraftPlant\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntar{\nTEXT-ALIGN: RIGHT\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n NASDAQ | TSX: ACB\n \n \n \n \n \n Canada's\n \n leading medical cannabis provider and\n \n Australia's\n \n preeminent medical cannabis supplier to bring three new premium strains to Australian patients\n \n \n \n \n \n \n EDMONTON, AB\n \n \n ,\n \n \n Feb. 22, 2023\n \n \n /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and MedReleaf Australia today announced the launch of CraftPlant, a new medical cannabis brand for patients in the Australian market.\n \n \n \n \n \n \n \n \n \n The CraftPlant brand includes three new products available for doctors to prescribe – Greendae, Navana and HiVolt. All three are developed from ultra-premium cultivars and are THC-dominant with high percentages of terpenes. The cultivars were developed by\n \n Occo\n \n , Aurora's leading science and genetics business. The new range is produced under strict EU-GMP certified conditions and will be available in 10g containers.\n \n \n \"Through our partnership with MedReleaf Australia, we are proud to continue to lead the way in the Australian market with the addition of new and innovative products for patients,\" says\n \n Miguel Martin\n \n , CEO of Aurora Cannabis. \"As we build on our strategic international growth plans,\n \n Australia\n \n has proven to be a very promising and sustainable cannabis market that we are committed to.\"\n \n \n Aurora currently holds a 10% ownership stake in MedReleaf Australia, a fully licensed, private company. Together, they provide Australian patients with several Aurora-branded products, including dried flower, oils and soft gels.\n \n \n \n Russell Harding\n \n , CEO of MedReleaf Australia says, \"These new products are the result of dedicated hard work by the teams in both\n \n Canada\n \n and\n \n Australia\n \n , providing the most unique cannabi...